C12N2310/32 - page 2 - CPC Classification Index

#301

20150196648

2015-07-16

Methods and compositions for treating prostate cancer

#302

20150152411

2015-06-04

METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION

#303

20150132761

2015-05-14

Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications

#304

20150126587

2015-05-07

Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63

#305

20140357856

2014-12-04

CHIMERIC OLIGOMERIC COMPOUNDS COMPRISING ALTERNATING REGIONS OF NORTHERN AND SOUTHERN CONFORMATIONAL GEOMETRY

#306

20140350088

2014-11-27

Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same

#307

20140343122

2014-11-20

Compositions and methods for inhibiting expression of factor VII gene

#308

20140336370

2014-11-13

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#309

20140329882

2014-11-06

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#310

20140068797

2014-03-06

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

#311

20140057963

2014-02-27

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#312

20130203977

2013-08-08

Oligonucleotides comprising alternating segments and uses thereof

#313

20130130378

2013-05-23

Oligonucleotides comprising acyclic and abasic nucleosides and analogs

#314

20130065951

2013-03-14

COMPOSITIONS AND METHODS RELATED TO MIRNA MODULATION OF NEOVASCULARIZATION OR ANGIOGENESIS

#315

20130035373

2013-02-07

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

#316

20120329727

2012-12-27

Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2

#317

20120295953

2012-11-22

Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63

#318

20120289583

2012-11-15

TREATMENT OF INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 AND TRANSCRIPTION FACTOR E3 (TFE3)

#319

20120288476

2012-11-15

Structure and use of 5′ phosphate oligonucleotides

#320

20120283319

2012-11-08

Method of inhibiting miR-33 using a modified oligonucleotide

#321

20120283312

2012-11-08

Modulation of eIF4E expression

#322

20120252027

2012-10-04

Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications

#323

20120208860

2012-08-16

Compositions and methods for inhibiting expression of factor VII gene

#324

20120172420

2012-07-05

Method for modulating responsiveness to steroids

#325

20120157514

2012-06-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#326

20120129917

2012-05-24

Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin

#327

20120122216

2012-05-17

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#328

20120071641

2012-03-22

Nucleic acid chemical modifications

#329

20120064048

2012-03-15

Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor

#330

20120035248

2012-02-09

Method for inhibiting the activity of mir-155

#331

20110313020

2011-12-22

UNA oligomer structures for therapeutic agents

#332

20110306652

2011-12-15

Compositions and their uses directed to huntingtin

#333

20110257248

2011-10-20

RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis

#334

20110251263

2011-10-13

RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof

#335

20110224277

2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#336

20110190376

2011-08-04

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

#337

20110178157

2011-07-21

Modulation of HSP47 expression

#338

20110136233

2011-06-09

NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF

#339

20110118456

2011-05-19

Interfering RNA molecules

#340

20110098456

2011-04-28

Immune stimulatory oligonucleotide analogs containing modified sugar moieties

#341

20110086901

2011-04-14

OLIGONUCLEOTIDES AFFECTING EXPRESSION OF PHOSPHODIESTERASES

#342

20100324277

2010-12-23

Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation

#343

20100298410

2010-11-25

MicromiRs

#344

20100280099

2010-11-04

Combination treatment for the treatment of hepatitis C virus infection

#345

20100267813

2010-10-21

Method for inhibiting the activity of mir-155

#346

20100267811

2010-10-21

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

#347

20100249215

2010-09-30

Oligomeric compounds and compositions for use in modulation of pri-miRNAs

#348

20100234446

2010-09-16

RNAi modulation of the BCR-ABL fusion gene and uses thereof

#349

20100234241

2010-09-16

DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES

#350

20100203544

2010-08-12

DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER ASSOCIATED CHROMOSOMAL FEATURES

#351

20100178272

2010-07-15

STRUCTURE AND USE OF 5'PHOSPHATE OLIGONUCLEOTIDES

#352

20100166805

2010-07-01

Modulation of immunostimulatory properties by small oligonucleotide-based compounds

#353

20100130589

2010-05-27

MODULATION OF eIF4E EXPRESSION

#354

20100069472

2010-03-18

COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

#355

20100048673

2010-02-25

Oligonucleotides affecting expression of phosphodiesterases

#356

20090317907

2009-12-24

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#357

20090298174

2009-12-03

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#358

20090291907

2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#359

20090291906

2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#360

20090286969

2009-11-19

Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs

#361

20090281167

2009-11-12

Compositions and methods related to miRNA modulation of neovascularization or angiogenesis

#362

20090264511

2009-10-22

Compositions and methods for inhibiting expression of factor VII gene

#363

20090258931

2009-10-15

Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry

#364

20090221807

2009-09-03

2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid

#365

20090198047

2009-08-06

2'-Modified Oligonucleotides

#366

20090192106

2009-07-30

Modulation of eIF4E expression

#367

20090186849

2009-07-23

Antisense antiviral compounds and methods for treating a filovirus infection

#368

20090186848

2009-07-23

Antisense antiviral compounds and methods for treating a filovirus infection

#369

20090186847

2009-07-23

Antisense antiviral compounds and methods for treating a filovirus infection

#370

20090186845

2009-07-23

Interfering RNA molecules

#371

20090143326

2009-06-04

MicroRNAs

#372

20090105467

2009-04-23

Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues

#373

20090036397

2009-02-05

RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA

#374

20090036396

2009-02-05

RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS

#375

20080318885

2008-12-25

Method for modulating responsiveness to steroids

#376

20080293662

2008-11-27

RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF

#377

20080261904

2008-10-23

Chimeric Gapped Oligomeric Compounds

#378

20080254443

2008-10-16

Norovirus detection, methods and compositions therefor

#379

20080146788

2008-06-19

Positionally modified siRNA constructs

#380

20080119427

2008-05-22

Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation

#381

20080039418

2008-02-14

Compositions and their uses directed to huntingtin

#382

20080032945

2008-02-07

2'-MODIFIED OLIGONUCLEOTIDES

#383

20080027214

2008-01-31

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

#384

20070299027

2007-12-27

COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN

#385

20070292875

2007-12-20

Human RNase H1 oligonucleotide compositions thereof

#386

20070198203

2007-08-23

Data correction apparatus, data correction method, magnetic resonance imaging apparatus and X-ray CT apparatus

#387